Changing epidemiology of neovascular glaucoma from 2002 to 2012 at King Khaled Eye Specialist Hospital, Saudi Arabia
- PMID: 29044062
- PMCID: PMC5678333
- DOI: 10.4103/ijo.IJO_33_17
Changing epidemiology of neovascular glaucoma from 2002 to 2012 at King Khaled Eye Specialist Hospital, Saudi Arabia
Abstract
Purpose: The aim is to present the incidence and determinants of neovascular glaucoma (NVG) in Saudi Arabia.
Methods: A retrospective review of NVG cases (2002-2012) was included to estimate the incidence. The determinants included gender, age, comorbidities, lens status, type of NVG, and visual acuity on presentation. The impact of antiangiogenic therapy on NVG incidence was studied.
Results: We studied 597 eyes with NVG. The incidence was 6.6/10,000. It declined from 13/10,000 in 2008-0.1/10,000 in 2012 (P < 0.001). The decline in 2008 coincided with the introduction of intravitreal injection bevacizumab in Saudi Arabia. Males had a significantly higher NVG risk (odds ratio [OR] = 2.2). Diabetes and hypertension were associated with NVG in 88% and 42.7% of cases, respectively. In 377 (72%) diabetic patients, the glycemic control was poor (HbA1C >7%). Visual acuity was 20/20-20/40 in 14 (2%), 20/50-20/200 in 79 (13%), 20/200-20/400 in 456 (76%), and <20/400 in 45 (7%) eyes. Intraocular pressure was higher than 30 mmHg in 438 (73%) eyes. The cup-to-disc (CD) ratio was >0.8 in 86 (14%) eyes. During the early period (2002-2007) and later period (2008-2012), CD ratio (χ2 = 4, P = 0.09) and anterior chamber angle (P = 0.8) were not different. The presence of NVG in contralateral eye (OR = 0.8, P = 0.3) in both periods was similar.
Conclusions: NVG was associated with diabetes in a very large proportion of patients. It was significantly associated with males, and with poor glycemic control and poor vision at presentation. The incidence of NVG declined after the introduction of intravitreal bevacizumab.
Conflict of interest statement
There are no conflicts of interest.
Figures
Similar articles
-
Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab.Br J Ophthalmol. 2009 May;93(5):589-93. doi: 10.1136/bjo.2008.151472. Epub 2008 Dec 15. Br J Ophthalmol. 2009. PMID: 19074917
-
Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.Ophthalmology. 2008 Sep;115(9):1571-80, 1580.e1-3. doi: 10.1016/j.ophtha.2008.02.026. Epub 2008 Apr 28. Ophthalmology. 2008. PMID: 18440643
-
Neovascular Glaucoma Progress and Impact of Therapeutic Intervention in Saudi Arabia.Cureus. 2021 Sep 3;13(9):e17696. doi: 10.7759/cureus.17696. eCollection 2021 Sep. Cureus. 2021. PMID: 34650870 Free PMC article.
-
Neovascular glaucoma: a retrospective review from a tertiary center in China.BMC Ophthalmol. 2016 Jan 27;16:14. doi: 10.1186/s12886-016-0190-8. BMC Ophthalmol. 2016. PMID: 26818828 Free PMC article. Review.
-
Neovascular glaucoma: Handling in the future.Taiwan J Ophthalmol. 2018 Apr-Jun;8(2):60-66. doi: 10.4103/tjo.tjo_39_18. Taiwan J Ophthalmol. 2018. PMID: 30038883 Free PMC article. Review.
Cited by
-
Two-year outcomes of patients presenting to Sydney Eye Hospital with neovascular glaucoma.Int Ophthalmol. 2023 Aug;43(8):2763-2776. doi: 10.1007/s10792-023-02675-5. Epub 2023 Mar 13. Int Ophthalmol. 2023. PMID: 36913166 Free PMC article.
-
Murphy's Law and Ophthalmic Complications in a Patient With Type 1 Diabetes Mellitus.Cureus. 2023 Jun 18;15(6):e40584. doi: 10.7759/cureus.40584. eCollection 2023 Jun. Cureus. 2023. PMID: 37469817 Free PMC article.
-
Altered Intrinsic Functional Connectivity of the Primary Visual Cortex in Patients with Neovascular Glaucoma: A Resting-State Functional Magnetic Resonance Imaging Study.Neuropsychiatr Dis Treat. 2020 Jan 7;16:25-33. doi: 10.2147/NDT.S228606. eCollection 2020. Neuropsychiatr Dis Treat. 2020. PMID: 32021196 Free PMC article.
-
Profile of newly referred glaucoma patients to the largest tertiary eye care hospital in Saudi Arabia.Saudi J Ophthalmol. 2024 Jul 3;38(4):380-386. doi: 10.4103/sjopt.sjopt_76_23. eCollection 2024 Oct-Dec. Saudi J Ophthalmol. 2024. PMID: 39943955 Free PMC article.
-
Early Surgical Intervention for Neovascular Glaucoma in a Patient with Diabetes.Cureus. 2021 Jun 3;13(6):e15420. doi: 10.7759/cureus.15420. Cureus. 2021. PMID: 34113524 Free PMC article.
References
-
- Sivak-Callcott JA, O’Day DM, Gass JD, Tsai JC. Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma. Ophthalmology. 2001;108:1767–76. - PubMed
-
- Sarwat S, Scott IU, Fekrat S. Ophthalmic Pearls: Glaucoma Eye Net American Academy of Ophthalmology. [Last accessed on 2017 Jan 11]. Available from: http://www.aao.org/publications/eyenet/200607/pearls.cfm .
-
- Shazly TA, Latina MA. Neovascular glaucoma: Etiology, diagnosis and prognosis. Semin Ophthalmol. 2009;24:113–21. - PubMed
-
- SooHoo JR, Seibold LK, Kahook MY. Recent advances in the management of neovascular glaucoma. Semin Ophthalmol. 2013;28:165–72. - PubMed
-
- Iliev ME, Domig D, Wolf-Schnurrbursch U, Wolf S, Sarra GM. Intravitreal bevacizumab (Avastin®) in the treatment of neovascular glaucoma. Am J Ophthalmol. 2006;142:1054–6. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources